Metabolic effect of 3,3',5'-triiodothyronine in cultured growth hormone-producing rat pituitary tumor cells. Evidence for a unique mechanism of thyroid hormone action
- PMID: 4031075
- PMCID: PMC423928
- DOI: 10.1172/JCI112049
Metabolic effect of 3,3',5'-triiodothyronine in cultured growth hormone-producing rat pituitary tumor cells. Evidence for a unique mechanism of thyroid hormone action
Abstract
Physiologic levels of 3,3',5'-triiodothyronine (rT3) are generally believed to have minimal metabolic effects in the pituitary gland and other tissues. In the present studies, the regulatory role of rT3 and other thyroid hormones on iodothyronine 5'-deiodinase (I5'D) activity was studied in a growth hormone-producing rat pituitary tumor cell line (GH3 cells). I5'D activity was thiol-dependent and displayed nonlinear reaction kinetics suggesting the presence of two enzymatic processes, one having a low Michaelis constant (Km for thyroxine [T4] of 2 nM) and a second with a high Km value (0.9 microM). Growth of cells in hormone-depleted medium resulted in a two- to 3.5-fold increase in low Km I5'D activity (P less than 0.001). The addition of thyroid hormones to the culture medium resulted in a rapid, dose-dependent inhibition of low Km I5'D activity with the following order of analogue potency: rT3 greater than or equal to T4 greater than 3,5,3'-triiodothyronine (T3). Using serum-free culture conditions, rT3 was approximately 50 times more active than T3. These inhibitory effects were noted within 15 min of hormone addition and could not be attributed to substrate competition with T4. These findings suggest that the control of T4 to T3 conversion by thyroid hormones in the anterior pituitary gland is mediated by a unique cellular mechanism that is independent of the nuclear T3 receptor; and under some circumstances, rT3 may play a regulatory role in controlling this enzymatic process.
Similar articles
-
Hormonal control of a low Km (type II) iodothyronine 5'-deiodinase in cultured NB41A3 mouse neuroblastoma cells.Endocrinology. 1986 Aug;119(2):840-6. doi: 10.1210/endo-119-2-840. Endocrinology. 1986. PMID: 3525124
-
Thyroxine 5'-deiodinase activity in anterior pituitary glands transplanted under the renal capsule in the rat.Endocrinology. 1985 Jul;117(1):55-63. doi: 10.1210/endo-117-1-55. Endocrinology. 1985. PMID: 4006866
-
Regulatory effect of lithium on thyroxine metabolism in murine neural and anterior pituitary tissue.Endocrinology. 1987 Apr;120(4):1430-8. doi: 10.1210/endo-120-4-1430. Endocrinology. 1987. PMID: 3030700
-
The role of thyroid hormone deiodination in the regulation of hypothalamo-pituitary function.Neuroendocrinology. 1984 Mar;38(3):254-60. doi: 10.1159/000123900. Neuroendocrinology. 1984. PMID: 6371572 Review.
-
Clinical and laboratory aspects of 3,3',5'-triiodothyronine (reverse T3).Ann Clin Biochem. 2021 Jan;58(1):29-37. doi: 10.1177/0004563220969150. Epub 2020 Nov 4. Ann Clin Biochem. 2021. PMID: 33040575 Review.
Cited by
-
Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues.J Clin Invest. 1996 Jul 15;98(2):405-17. doi: 10.1172/JCI118806. J Clin Invest. 1996. PMID: 8755651 Free PMC article.
-
Restoration of type 1 iodothyronine deiodinase expression in renal cancer cells downregulates oncoproteins and affects key metabolic pathways as well as anti-oxidative system.PLoS One. 2017 Dec 22;12(12):e0190179. doi: 10.1371/journal.pone.0190179. eCollection 2017. PLoS One. 2017. PMID: 29272308 Free PMC article.
-
Transcriptional regulation of mammalian selenoprotein expression.Biochim Biophys Acta. 2009 Nov;1790(11):1429-40. doi: 10.1016/j.bbagen.2009.05.012. Epub 2009 May 22. Biochim Biophys Acta. 2009. PMID: 19465084 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical